Our findings are similar to a recent study defining immune triads that contain tumor-specific cytotoxic CD8+ T cells, CD4+ T cells, and antigen-presenting dendritic cells required to license tumor specific CD8+ T cells to eliminate cancer (78). The gene discussed is CD8A; the disease is cancer.